NG
NGVT.US Ingevity Corp
- Market cap
- USD 2.08B
- P/E
- 58.8x
- P/B
- 33.09x
- ROE
- 305.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is NGVT.US undervalued?
Graham numberThe Graham number of Ingevity Corp cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ingevity Corp fundamental analysis
No fundamental analysis for Ingevity Corp yet.
Ingevity Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ingevity Corp
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline va…
Full company profileIngevity Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Ingevity Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 908M | 972M | 1.13B | 1.29B | 1.22B | 1.39B | 1.67B | 1.69B | 1.41B | 1.17B | 1.17B |
| Gross Profit | 274M | 329M | 417M | 482M | 466M | 513M | 570M | 472M | 455M | 462M | 518M |
| Operating Income | 160M | 203M | 263M | 328M | 298M | 307M | 341M | 256M | 260M | 262M | 287M |
| EBITDA | 199M | 243M | 320M | 413M | 382M | 324M | 440M | 206M | -330M | 37.4M | 333M |
| Net Income | 35.2M | 126M | 169M | 184M | 181M | 118M | 212M | -5.40M | -430M | -167M | 193M |
| EPS | 0.83 | 2.97 | 3.97 | 4.35 | 4.37 | 2.95 | 5.50 | -0.15 | -12 | -4.62 | 5.52 |
| Balance Sheet | |||||||||||
| Total Assets | 833M | 930M | 1.32B | 2.14B | 2.33B | 2.47B | 2.74B | 2.62B | 2.02B | 1.65B | 1.50B |
| Total Liabilities | 698M | 653M | 976M | 1.61B | 1.69B | 1.80B | 2.04B | 1.99B | 1.83B | 1.62B | 1.44B |
| Shareholders' Equity | 135M | 278M | 340M | 531M | 647M | 674M | 698M | 631M | 195M | 29.7M | 63.0M |
| Cash & Short-term Investments | 30.5M | 87.9M | 77.5M | 56.5M | 258M | 275M | 76.7M | 95.9M | 68.0M | 78.1M | 85.4M |
| Total Debt | 489M | 453M | 752M | 1.27B | 1.31B | 1.29B | 1.53B | 1.53B | 1.45B | 1.24B | 1.18B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 128M | 174M | 252M | 276M | 352M | 293M | 313M | 205M | 129M | 331M | 111M |
| Capital Expenditure | 56.7M | 52.6M | 93.9M | 115M | 106M | 104M | 143M | 110M | 77.6M | 57.7M | 45.7M |
| Free Cash Flow | 71.2M | 122M | 158M | 161M | 247M | 190M | 171M | 95.3M | 51.0M | 274M | 65.5M |
| Ratios | |||||||||||
| ROE | 26.2% | 45.5% | 49.8% | 34.6% | 28.0% | 17.5% | 30.3% | -0.9% | -220.4% | -562.6% | 305.6% |
| ROA | 4.2% | 13.6% | 12.9% | 8.6% | 7.8% | 4.8% | 7.7% | -0.2% | -21.3% | -10.1% | 12.8% |
| Net Profit Margin | 3.9% | 13.0% | 14.9% | 14.2% | 14.9% | 8.5% | 12.7% | -0.3% | -30.6% | -14.3% | 16.5% |
| Debt to Equity | 3.63x | 1.63x | 2.22x | 2.39x | 2.02x | 1.91x | 2.19x | 2.43x | 7.45x | 41.84x | 18.71x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Ingevity Corp dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | USD 4.10M | 0.11 | 1.9% |
| 2021 | USD 4.70M | 0.12 | 4.0% |
| 2020 | USD 3.60M | 0.09 | 2.0% |
| 2019 | USD 4.10M | 0.10 | 2.2% |
| 2018 | USD 15.3M | 0.36 | 9.0% |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Ingevity Corp
- Insiders 1.18%
- Institutions 98.82%
- Public & others 0.00%
- Shares outstanding 33.8M
- Free float 33.5M
Top funds holding NGVT.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 2.07M | 6.09% | -0.11% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.11M | 3.26% | -0.52% | Sep 2026 |
| iShares Russell 2000 ETF | 890K | 2.62% | 0.00% | Oct 2026 |
| Vanguard Small Cap Index | 774K | 2.28% | -3.19% | Sep 2026 |
| American Century Small Cap Value Inv | 665K | 1.96% | +5.56% | Sep 2026 |
| Vanguard MStar Small Cap Value Index | 504K | 1.48% | -0.89% | Sep 2026 |
| Brown Advisory Small-Cap Fdmtl Val Inv | 487K | 1.43% | -1.26% | Sep 2026 |
| T. Rowe Price New Horizons | 439K | 1.29% | 0.00% | Sep 2026 |
| Fidelity Small Cap Index | 389K | 1.14% | +0.22% | Aug 2026 |
| iShares Russell 2000 Growth ETF | 329K | 0.97% | -0.38% | Oct 2026 |
| State Street SPDR Port S&P 600 Sm CpETF | 315K | 0.93% | -0.05% | Oct 2026 |
| Royce Small-Cap Total Return Invmt | 289K | 0.85% | -15.55% | Sep 2026 |
| Fidelity Select Chemicals | 278K | 0.82% | +38.43% | Sep 2026 |
| Bridge Builder Small Cap Fund | 224K | 0.66% | +21.98% | Oct 2026 |
| Vanguard Tax-Managed Small Cap Adm | 223K | 0.66% | 0.00% | Sep 2026 |
| Vanguard Russell 2000 ETF | 205K | 0.60% | -0.17% | Sep 2026 |
| Principal SmallCap R5 | 193K | 0.57% | -2.53% | Sep 2026 |
| Invesco S&P SmallCap Momentum ETF | 192K | 0.57% | 0.00% | Oct 2026 |
| Vanguard Strategic Equity Inv | 185K | 0.55% | +57.72% | Sep 2026 |
| Schwab US Small-Cap ETF™ | 183K | 0.54% | +0.23% | Oct 2026 |
Top institutions holding NGVT.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 5.36M | 15.79% | +1.26% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 2.38M | 7.00% | +9.19% | Jun 2026 |
| Vanguard Capital Management, LLC | 1.57M | 4.63% | -0.68% | Jun 2026 |
| State Street Corp | 1.50M | 4.41% | +2.61% | Jun 2026 |
| American Century Companies Inc | 1.37M | 4.03% | +7.79% | Sep 2026 |
| Wellington Management Company LLP | 1.08M | 3.17% | -28.03% | Jun 2026 |
| Segall Bryant & Hamill | 1.05M | 3.11% | -4.91% | Jun 2026 |
| Millennium Management LLC | 992K | 2.92% | -14.14% | Jun 2026 |
| Brown Advisory Holdings Inc | 974K | 2.87% | -1.81% | Jun 2026 |
| Royce & Associates, LP | 940K | 2.77% | +6.44% | Jun 2026 |
| Geode Capital Management, LLC | 919K | 2.71% | +3.61% | Jun 2026 |
| Simcoe Capital Management, LLC | 894K | 2.63% | -8.96% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 786K | 2.31% | -0.21% | Sep 2026 |
| T. Rowe Price Associates, Inc. | 747K | 2.20% | +24.78% | Jun 2026 |
| Harvey Partners LLC | 734K | 2.16% | -1.24% | Jun 2026 |
| Principal Financial Group Inc | 691K | 2.03% | -9.37% | Sep 2026 |
| Victory Capital Management Inc. | 681K | 2.00% | -8.13% | Jun 2026 |
| The Goldman Sachs Group Inc | 633K | 1.86% | +10.12% | Jun 2026 |
| Maple Rock Capital Partners, Inc. | 603K | 1.78% | 0.00% | Jun 2026 |
| Charles Schwab Investment Management Inc | 541K | 1.59% | -10.99% | Jun 2026 |
Ingevity Corp company profile
- Company name
- Ingevity Corp
- Ticker
- NGVT.US
- Exchange
- USA Stocks
- Listed since
- May 2, 2016
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 1,400
- Fiscal year end
- December
- Address
- 4920 O'Hear Avenue, North Charleston, SC, United States, 29405
- Phone
- 843 740 2300
- Website
- ingevity.com
About Ingevity Corp
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, lubricants, certain adhesives, rubber, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts manufacturers through sales representatives, third-party sales representatives, and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
Ingevity Corp management
10- Mr. David H. LiPresident, CEO & Director · born 1973
- Mr. Ryan C. FisherSenior VP, General Counsel & Secretary · born 1976
- Mr. Terrance M. DyerSenior VP & Chief Human Resources Officer · born 1967
- Mr. Phillip John PlattSenior VP & CFO · born 1981
- Mr. Reid ClontzSenior Vice President of Operations · born 1974
- Mr. Ryan CottermanVice President, Chief Accounting Officer & Principal Accounting Officer · born 1982
- Mr. Michael H. WalshVice President of Investor Relations
- Ms. Caroline MonahanDirector of Communications
- Mr. Michael N. ShukovSenior VP & President of Advanced Polymer Technologies · born 1969
- Ms. Ruth CastilloSenior VP & President of Performance Materials · born 1978